Description: Multiple cervix cancer with cervix tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing CR1001a

Description: Cervix cancer tissue array for antibody screening, including pathology grade, TNM and clinical stage, 50 cases/100 cores

Description: Cervix cancer tissue array with normal cervix tissue, including TNM, clinical stage and pathology grade, 12 cases/ 24 cores, replacing T103a

Description: Cervix cancer with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 65 cases/80 cores, replacing CR802

Description: Cervix cancer tissue array with adjacent normal cervix tissue, including TNM, clinical stage, pathology grade and IHC markers (HPV16/18 and Ki67) results, 110 cases/110 cores

Description: Cervix cancer tissue array with matched adjacent cervix tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores,replacing CR245

Description: Cervix squamous cell carcinoma with normal adjacent cervix tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores (1.5mm), replacing CR243a

Description: Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases/48 cores

Description: Cervix cancer tissue array, including squamous cell carcinoma, glassy cell carcinoma and adenocarcinoma, pathology grade, TNM and clinical stage, 6 cases/24 cores (1.5mm), replacing T104

Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Cervix tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Description: Cervix cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data) tissues.

Description: Cervical cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Description: Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing CR241

Description: Cervix cancer and normal tissue array, with stage and grade info, 80 cases/80 cores

Description: Cervix cancer with normal tissue array, including pathology grade, TNM and clinical stage, 22 cases/24 cores (1.5mm), replacing CR246

Description: The Matched Pair Paraffin Tissue (MPPT) slides are designed for identifying tumor-specific/metastasis genes or proteins. Slices from normal and malignant tissues are mounted on each MPPT slide which can then be treated as a single histological slide for H&E staining, immunohistochemistry, or in situ hybridization. This format allows a rapid analysis of protein expression and localization across normal and cancerous tissue.

Description: High-density uterine cervix cancer array, with normal cervical tissue,including TNM, clinical stage, pathology grade and IHC markers HPV16/18 results, 322 cases/616 cores

Description: Uterine cervix disease spectrum tissue array, including TNM, clinical stage and pathology grade, 60 cases/ 60 cores, replacing CR602

Description: Cervical cancer tissue array, set 1, non-overlapping with CXC1502 or CXC1503, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.

Description: Cervical cancer tissue array, set 2, non-overlapping with CXC1501 or CXC1503, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.

Description: Cervical cancer tissue array, set 3,, non-overlapping with CXC1501 or CXC1502, consisting of 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.

Description: Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores

Description: Cervix cancer survey tissue array (1 of 2), with normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores (core size 1.0mm), replacing CR2088

Description: Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases/208 cores (core size 1.0mm), replacing CR2089

Description: Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases/72 cores

Description: Cervix cancer and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T102a

Description: Mid-advanced stage cervix cancer tissue array, with metastasis tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores